주요우울증 환자에서 세로토닌 6 (5-HT6) 수용체 C267T 다형성과 citalopram 치료반응에 대한 연구
No association between the 5-HT6 receptor C267T polymorphism and response to citalopram treatment in patient with major depressive disorder
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
The serotonin 6 (5-HT6) receptor gene is a candidate gene for influencing the clinical response to treatment with antidepressants. The purpose of this study was to determine the relationship between the C267T polymorphism in the 5-HT6 receptor gene and the treatment response to citalopram in a Korean population with major depressive disorder (MDD). Citalopram was administered for 8 weeks to the 90 patients who completed study. We found that the genotype, allele, and allele-carrier distributions did not differ significantly between MDD patients and normal controls. A main effect of an interaction of genotype with time on the decrease in the HAMD-21 score during the 8 weeks study period was not found. ANOVA revealed no significant effects of the C825T polymorphism on the decrease in the HAMD-21 score at each time period.These results suggest that the C267T polymorphism in the 5-HT6 receptor gene is not associated with citalopram treatment response. Key WordsMajor depressive disorder, 5-HT6 receptor , C267T polymorphism, citalopram.
참고문헌 (35)
- Barnes NM, "A review of central 5-HT receptors and their function.", 38, pp.10831152~ (1999)
- Iversen L, "The monoamine hypothesis of depression.", pp.7186~ (2005), Weinheim, Germany: Wiley-VCH.
- Hoyer D, "International union of pharmacology classification of receptors for 5-hydroxytryptamine"
- Heninger GR, "The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.", 29, pp.211~ (1996)
- Ro 63-0563labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum., , 1998, 577~583
- Gerard, C, "Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7- dihydroxytryptamine-treated rats.", 23, pp.164~173 (1996)
- Gerard, C, "Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system.", 23, pp.207~219 (1997)
- Ward, R.P, "Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.", 64, pp.1105~1111 (1995)
- Yoshioka, M, "Centraldistribution and function of 5-HT6 receptor subtype in the rat brain.", 62, pp.1473~1477 (1998)
- Sanacora, G, "Increasedoccipital cortex GABA concentrations in depressed patients after therapywith selective serotonin reuptake inhibitors.", 158(4), pp.663665~ (2002)
- Schechter, L. E, "WAY-466: in vitro and in vivo pharmacological characterization of a noveland selective 5-HT6 receptor agonist.", 29, pp.S237~ (2004)
- Beyer, C. E, "SAX-187: neurochemical profile of a novel and selective 5-HT6 receptoragonist.", pp.~187 (2005)
- Russo-Neustadt, "Brain-derived neurotrophic factor and antidepressant activity.", 11(12), pp.14951510~ (2005)
- Millan, M.J.,, "The neurobiology and control of anxious states.", 70, pp.83~244 (2003)
- Mitchell, E.S, "5-HT6 receptors: a novel target for cognitive enhancement.", 108, pp.320~333 (2005)
- Schechter, L.E, "Innovative approaches for the development of antidepressant drugs: current and future strategies.", 2, pp.590~611 (2005)
- Woolley, M.L, "5-ht6 receptors.", 3, pp.59~79 (2004)
- Monsma FJ Jr, "Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs." (1993)
- Wu, W. H, "Association study of the 5-HT (6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders.", 44, pp.172175~ (2004)
- Yu YW, "Serotonin-6 receptor variant (C267T) and clinical response to clozapine.", 10 (1999), 12311233
- receptor gene in bipolar affective disorder and schizophrenia., , 2006, 21721~
- Hamilton M, "Development of a rating scale for primary depressive illness"
- Monsma, "Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs", pp.320~327
- "Molecular cloning of a mammalianserotonin receptor that activates adenylate cyclase", pp.229~236
- Diaz, "localization and stimulation of cAMP accumulation", pp.5 268~276
- Gerard, C, "Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7- dihydroxytryptamine-treated rats.", 23, pp.164~173 (1996)
- Ward, R.P, "Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.", 64, pp.1105~1111 (1995)
- Russo-Neustadt AA, "Brain-derived neurotrophic factor and antidepressant activity.", 11, pp.14951510~ (2005)
- De Foubert G, "5-HT6 receptor-selective upregulation of brain-derived neurotrophic factor mRNA in the rat brain." (2004), Federation of European Neuroscience Societies
- Boess, F.G, "Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.", 36, pp.713~720 (1997)
- Ro 63-0563labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum., , 1998, 577~583
- Monsma, "Cloningand expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs", pp.320~327
- Sebben, "5-HT6 receptorspositively coupled to adenylyl cyclase in striatal neurons in culture", pp.2553~2557
- Arias B, "5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.", 23, pp.563567~ (2003)
- Lee, S. H, "Association between the 5-HT6 receptor C267T polymorphism and response to antidepressants treatment in major depressive disorder.", 59, pp.140145~ (2005)
